Major Depressive Disorder Patients Clinical Trial
Official title:
Phase I Study of FK949E - Multiple Dose Study of Elderly Adult Patients With Major Depressive Disorder
The objective of the study was to evaluate the safety and plasma concentration changes of quetiapine after multiple oral administration of FK949E (extended-release formulation of quetiapine) in elderly patients with major depressive disorder (MDD).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01871974 -
Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder
|
Phase 1 |